tosilate

Suplatast Tosilate (IPD 1151T) is a novel capsular anti-asthmatic drug with an IC50 above 100 μM, inhibiting both IgE production and the synthesis of IL-4 and IL-5.

Tosufloxacin tosilate is a fluoroquinolone antibiotic.

Tosufloxacin (Ozex) is a quinolone antimicrobial agent and potent inhibitor of the metabolism of theophylline.

Tosufloxacin tosylate hydrate (Standard) is the standard substance of Tosufloxacin tosylate hydrate, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Tosufloxacin tosylate hydrate (A-61827 tosylate hydrate) is a fluoroquinolone antibacterial agent that is used to treat susceptible infections.

Lapatinib ditosylate (Lapatinib tosilate) monohydrate is a tyrosine kinase receptor inhibitor used in the therapy of advanced breast cancer and other solid tumors. Lapatinib ditosylate monohydrate therapy is associated with transient elevations in serum aminotransferase levels and rare instances of clinically apparent acute liver injury.

Trethinium is a tetrahydroisoquinoline derivative that possesses antihypertensive properties.

Emilium, an antiarrhythmic compound and cardiac depressant, is used for treating various types of arrhythmias.

Suplatast Tosylate-D5 is a deuterated compound of Suplatast Tosylate. Suplatast Tosylate (T0117) has a CAS number of 94055-76-2. Suplatast Tosilate is a novel capsular anti-asthmatic drug. It ( IC50 above 100 μM) inhibits both IgE production, IL-4 and IL-5 synthesis.